Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Orexigen Therapeutics Inc. buy melinda

Start price
€44.80
18.09.10 / 50%
Target price
€55.00
23.12.10
Performance (%)
37.28%
End price
€61.50
23.12.10
Summary
This prediction ended on 23.12.10 with a price of €61.50. The BUY prediction by melinda for Orexigen Therapeutics Inc. saw massive gains of 37.28%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Orexigen Therapeutics Inc. - - - -
iShares Core DAX® 3.523% 3.763% 26.705% 22.165%
iShares Nasdaq 100 1.026% 2.380% 29.587% 39.491%
iShares Nikkei 225® -0.063% 0.000% 15.214% 2.291%
iShares S&P 500 0.557% 2.222% 27.662% 40.483%

Comments by melinda for this prediction

In the thread Orexigen Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 37.28%
Target price 55.000
Change
Ends at 23.12.10

Biopharma-

Orexigen Therapeutics ist ein biopharmazeutisches Unternehmen auf die Entwicklung von Medikamenten in der Behandlung von Fettleibigkeit konzentriert

Prediction Buy
Perf. (%) 37.28%
Target price 55.000
Change
Ends at 23.12.10

(Vom Mitglied beendet)

Stopped prediction by melinda for Orexigen Therapeutics Inc.

buy
Orexigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.48
18.04.17
€3.61
24.04.17
5.45%
24.04.17

buy
Orexigen Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.49
05.09.16
€3.83
06.02.17
14.26%
06.02.17